Showing results (241-250 of 280) with videos related to
Sort By:
Pageof 28
Nature|December 8, 2022
In vitro production of infectious Plasmodium falciparum sporozoitesAbraham G Eappen, Tao Li, Meghan Marquette, et al.Cell Reports|February 10, 2021
Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humansHenry J Sutton, Racheal Aye, Azza H Idris, et al.Science Translational Medicine|December 8, 2022
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malariaSodiomon B Sirima, Alphonse Ouédraogo, Alfred B Tiono, et al.The American Journal of Tropical Medicine and Hygiene|July 30, 2014
Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoitesSeif Shekalaghe, Mastidia Rutaihwa, Peter F Billingsley, et al.Malaria Journal|August 7, 2015
Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity ratesGloria P Gómez-Pérez, Almudena Legarda, Jose Muñoz, et al.Frontiers in Immunology|November 17, 2022
Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacyNatasha Kc, L W Preston Church, Pouria Riyahi, et al.The Lancet. Infectious Diseases|August 17, 2024
Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsHalimatou Diawara, Sara A Healy, Agnes Mwakingwe-Omari, et al.Nature Medicine|September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trialMartina Oneko, Laura C Steinhardt, Reuben Yego, et al.The Lancet. Infectious Diseases|November 21, 2021
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trialMahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.Nature Immunology|April 23, 2021
Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunitySanne E de Jong, Vincent van Unen, Mikhael D Manurung, et al.Pageof 28